Right ventricular failure after left ventricular assist devices.
Most patients with advanced systolic dysfunction who are assessed for a left ventricular assist device (LVAD) also have some degree of right ventricular (RV) dysfunction. Hence, RV failure (RVF) remains a common complication of LVAD placement. Severe RVF after LVAD implantation is associated with increased peri-operative mortality and length of stay and can lead to coagulopathy, altered drug metabolism, worsening nutritional status, diuretic resistance, and poor quality of life. However, current medical and surgical treatment options for RVF are limited and often result in significant impairments in quality of life. There has been continuing interest in developing risk models for RVF before LVAD implantation. This report reviews the anatomy and physiology of the RV and how it changes in the setting of LVAD support. We will discuss proposed mechanisms and describe biochemical, echocardiographic, and hemodynamic predictors of RVF in LVAD patients. We will describe management strategies for reducing and managing RVF. Finally, we will discuss the increasingly recognized and difficult to manage entity of chronic RVF after LVAD placement and describe opportunities for future research.
Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio. Electronic address: brent.lampert@osumc.edu.
Brent C
BC
Lampert
Heart and Vascular Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
Jeffrey J
JJ
Teuteberg
D002908:Chronic Disease; D004452:Echocardiography; D006333:Heart Failure / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D006352:Heart Ventricles; D006353:Heart-Assist Devices; D006439:Hemodynamics; D006801:Humans; D008954:Models, Biological; D011183:Postoperative Complications; D011788:Quality of Life; D016278:Ventricular Function, Right
RVF predictors; left ventricular assist device; peri-operative mortality; right ventricular failure; risk models